Skip to content

CRDL.CA

Cardiol Therapeutics, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · CA

Ask drillr
  • Sep 16, 2026, 11:27 UTC

    Cardiol Therapeutics announced the exercise of warrants for over USD 7 million in proceeds, strengthening its balance sheet ahead of Phase III MAVERIC trial data in recurrent pericarditis.

  • Sep 10, 2026, 21:00 UTC

    Cardiol Therapeutics filed a preliminary short form base shelf prospectus for up to US$150 million with Canadian securities regulators and a corresponding Form F-10 registration statement with the US SEC.